317 related articles for article (PubMed ID: 8230284)
21. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.
Kaldor JM; Day NE; Band P; Choi NW; Clarke EA; Coleman MP; Hakama M; Koch M; Langmark F; Neal FE
Int J Cancer; 1987 May; 39(5):571-85. PubMed ID: 3570550
[TBL] [Abstract][Full Text] [Related]
22. Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82.
Greene MH; Wilson J
Natl Cancer Inst Monogr; 1985 Dec; 68():191-217. PubMed ID: 4088298
[TBL] [Abstract][Full Text] [Related]
23. Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma.
Brennan P; Scélo G; Hemminki K; Mellemkjaer L; Tracey E; Andersen A; Brewster DH; Pukkala E; McBride ML; Kliewer EV; Tonita JM; Seow A; Pompe-Kirn V; Martos C; Jonasson JG; Colin D; Boffetta P
Br J Cancer; 2005 Jul; 93(1):159-66. PubMed ID: 15970927
[TBL] [Abstract][Full Text] [Related]
24. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
25. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
26. Incidence of second cancers in patients treated for Hodgkin's disease.
Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
[TBL] [Abstract][Full Text] [Related]
27. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC
Haematologica; 2006 Nov; 91(11):1481-8. PubMed ID: 17043014
[TBL] [Abstract][Full Text] [Related]
28. Second primary cancers following non-Hodgkin's lymphoma in Japan: increased risk of hepatocellular carcinoma.
Tanaka H; Tsukuma H; Teshima H; Ajiki W; Koyama Y; Kinoshita N; Masaoka T; Oshima A
Jpn J Cancer Res; 1997 Jun; 88(6):537-42. PubMed ID: 9263530
[TBL] [Abstract][Full Text] [Related]
29. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
30. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time.
Foss Abrahamsen A; Andersen A; Nome O; Jacobsen AB; Holte H; Foss Abrahamsen J; Kvaløy S
Ann Oncol; 2002 Nov; 13(11):1786-91. PubMed ID: 12419752
[TBL] [Abstract][Full Text] [Related]
31. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
32. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
[TBL] [Abstract][Full Text] [Related]
33. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
Hemminki K; Jiang Y; Steineck G
Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
[TBL] [Abstract][Full Text] [Related]
34. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
[TBL] [Abstract][Full Text] [Related]
36. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
37. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
38. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
[TBL] [Abstract][Full Text] [Related]
39. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
